صفحة النتائج 31 القطاع: الرعاية الصحية سوق الأسهم - العروض والأسعار
قائمة بجميع الأوراق المالية والأسهم مع الأسعار، والقيم السوقية، ونسبة السعر إلى الربح، والأرباح للسهم الواحد
جميع البلدان
- {{country.name}}
- جميع البلدان
- الولايات المتحدة (2520)
- الأرجنتين (22)
- أستراليا (185)
- النمسا (85)
- بلجيكا (15)
- البرازيل (96)
- كندا (378)
- تشيلي (9)
- الصين (423)
- جمهورية التشيك (1)
- الدنمارك (17)
- فنلندا (18)
- فرنسا (96)
- ألمانيا (1842)
- اليونان (4)
- هونغ كونغ (190)
- هنغاريا (2)
- الهند (227)
- إندونيسيا (25)
- أيرلندا (4)
- إسرائيل (56)
- إيطاليا (30)
- اليابان (212)
- ماليزيا (26)
- المكسيك (109)
- هولندا (4)
- نيوزيلندا (17)
- النرويج (27)
- بولندا (24)
- قطر (2)
- روسيا (7)
- سنغافورة (34)
- جنوب أفريقيا (13)
- كوريا الجنوبية (66)
- إسبانيا (13)
- سورينام (9)
- السويد (166)
- سويسرا (39)
- تايوان (179)
- تايلاند (68)
- تركيا (13)
- المملكة المتحدة (220)
جميع منصات التبادل
- {{item.name}}
- جميع منصات التبادل
- Amsterdam (4)
- Aquis AQSE (1)
- ASX (185)
- Athens (4)
- Brussels (15)
- BSE (107)
- Budapest (2)
- Buenos Aires (22)
- Canadian Sec (195)
- Cboe CA (10)
- Copenhagen (17)
- Dusseldorf (5)
- Frankfurt (1603)
- Hamburg (3)
- Helsinki (18)
- HKSE (190)
- IOB (106)
- Irish (4)
- Istanbul (13)
- Jakarta (25)
- Johannesburg (13)
- KSE (66)
- Kuala Lumpur (26)
- LSE (113)
- MCE (13)
- MCX (7)
- Mexico (109)
- Milan (30)
- Munich (52)
- NasdaqCM (455)
- NasdaqGM (217)
- NasdaqGS (392)
- NEO (1)
- NSE (120)
- NYSE (127)
- NYSE American (39)
- NZSE (17)
- Oslo (27)
- Other OTC (1290)
- Paris (96)
- Prague (1)
- Qatar (2)
- Riga (1)
- Santiago (9)
- São Paulo (96)
- Sapporo (3)
- Saudi (9)
- SES (34)
- Shanghai (190)
- Shenzhen (233)
- Stockholm (166)
- Stuttgart (77)
- Swiss (39)
- Taipei Exchange (149)
- Taiwan (30)
- Tel Aviv (56)
- Thailand (68)
- Tokyo (209)
- Toronto (70)
- TSXV (102)
- Vienna (85)
- Warsaw (24)
- XETRA (102)
الرعاية الصحية (7776)
جميع الصناعات
- {{item.name}}
- جميع الصناعات
- التكنولوجيا الحيوية (2608)
- شركات تصنيع الأدوية - عامة (279)
- شركات تصنيع الأدوية - متخصصة وعامة (1702)
- خطط الرعاية الصحية (57)
- منشآت الرعاية الطبية (554)
- متاجر التجزئة الصيدلانية (155)
- خدمات المعلومات الصحية (420)
- الأجهزة الطبية (913)
- الأدوات والمستلزمات الطبية (502)
- التشخيص والبحث (427)
- التوزيع الطبي (138)
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS |
|---|
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Predictive Technology PRED | $0.0001 — |
0
|
$89.88K — | $100 — | $0.0001 — | $0.0001 — | $89.88K — | 0 | -$0.08 — | |
| NxGen Brands NXGB | $0.0035 — |
0
|
$73.78K — | $999 — | $0.0002 — | $0.0002 — | $73.78K — | 0 | $0 — | |
| Pharnext S.C.A. ALPHA.PA | $0.01 0.01 USD |
0
|
$61.15K 66.84K USD | $200.76K 219.46K USD | $0.009199 0.01 USD | $0.01 0.01 USD | $61.15K 66.84K USD | 0 | -$200 -218.6 USD | |
| U.S. Stem Cell USRM | $0.0001 — |
0
|
$64.15K — | $2.34M — | $0.0001 — | $0.0001 — | $64.15K — | 0 | $0 — | |
| Amarantus BioScience AMBS | $0.0001 — |
0
|
$63.04K — | $68K — | $0.0001 — | $0.0001 — | $63.04K — | 0 | -$0.01 — | |
| Calithera Biosciences CALA | $0.01 — |
0
|
$60.91K — | $111 — | $0.01 — | $0.01 — | $60.91K — | 0 | -$7.94 — | |
| National Healthcare Logistics NHLG | $0.002299 — |
0
|
$58.13K — | $50K — | $0.002299 — | $0.002299 — | $58.13K — | 0 | $0 — | |
| Bloomios BLMS | $0.0008999 — |
0
|
$58.03K — | $100K — | $0.0008999 — | $0.0008999 — | $58.03K — | 0 | -$1.86 — | |
| Neurobiological NTII | $0 — |
0
|
$54.31K — | $1.1K — | $0 — | $0 — | $54.31K — | 0 | $0 — | |
| Statera Biopharma STAB | $0.0005999 — |
0
|
$42.85K — | $85.23K — | $0.0005999 — | $0.0005999 — | $42.85K — | 0 | -$2.36 — | |
| For The Earth FTEG | $0 — |
0
|
$37.02K — | $250K — | $0 — | $0 — | $37.02K — | 0 | $0 — | |
| Bhang BHNGF | $0 — |
0
|
$35.58K — | $10 — | $0 — | $0 — | $35.58K — | 0 | -$0.02 — | |
| MagForce AG MF6.SG | $0.001 0.0010 USD |
0
|
$29.93K 32.72K USD | $0 0 USD | $0.001 0.0010 USD | $0.001 0.0010 USD | $29.93K 32.72K USD | 0 | -$0.35 -0.3 USD | |
| Hemp HEMP | $0 — |
0
|
$23.74K — | $1.53M — | $0 — | $0 — | $23.74K — | 0 | $0 — | |
| North American Cannabis USMJ | $0 — |
0
|
$23.54K — | $48.81K — | $0 — | $0 — | $23.54K — | 0 | $0 — | |
| Amazonas Florestal AZFL | $0 — |
0
|
$16.41K — | $50K — | $0 — | $0 — | $16.41K — | 0 | $0 — | |
| Neovacs S.A. ALNEV.PA | $0.02 0.02 USD |
+4.65
|
$13.82K 15.11K USD | $180.19K 196.97K USD | $0.02 0.02 USD | $0.02 0.03 USD | $13.82K 15.11K USD | 0 | -$24.85 -27.1 USD | |
| Q BioMed QBIO | $0.0001 — |
0
|
$14.51K — | $12.38K — | $0.0001 — | $0.0001 — | $14.51K — | 0 | -$0.02 — | |
| Item 9 Labs INLB | $0.0001 — |
0
|
$10.24K — | $56.5K — | $0 — | $0.0001 — | $10.24K — | 0 | -$0.33 — | |
| Adhera Therapeutics ATRX | $0.0011 — |
0
|
$7.94K — | $100 — | $0.0011 — | $0.0011 — | $7.94K — | 0 | -$1.17 — | |
| BioLife Sciences BLFE | $0 — |
0
|
$3.18K — | $50 — | $0 — | $0 — | $3.18K — | 0 | -$0.04 — | |
| Patient Access PASO | $0 — |
0
|
$2.48K — | $1K — | $0 — | $0 — | $2.48K — | 0 | $0 — | |
| Omnimmune OMMH | $0.0001 — |
+49.25
|
$980 — | $169.07K — | $0.0001 — | $0.0001 — | $980 — | 0 | -$0.2 — | |
| Cannabis Strategic Ventures NUGS | $0 — |
-99
|
$368 — | $5K — | $0 — | $0 — | $368 — | 0 | $0 — | |
| SpectraScience SCIE | $0 — |
0
|
$223 — | $10K — | $0 — | $0 — | $223 — | 0 | -$0.01 — | |
| Safe Orthopaedics SA ALSAF.PA | $0.0004 0.00043 USD |
-33.33
|
$153 167.25 USD | $10.3M 11.26M USD | $0.0004 0.00043 USD | $0.0004 0.00043 USD | $153 167.25 USD | 0 | -$286.6 -313.4 USD | |
| Global WholeHealth Partners GWHP | $0 — |
0
|
$131 — | $103.3K — | $0 — | $0 — | $131 — | 0 | -$0.05 — | |
| Rebus RBSH | $0 — |
-99
|
$32 — | $3.86K — | $0 — | $0.0001 — | $32 — | 0.000050 | $0.02 — | |
| The Flowr FLWPF | $0 — |
0
|
$0 — | $200 — | $0 — | $0 — | $0 — | 0 | $0 — | |
| RASPBERRY PI . LS -,0025 0IK.F | $4.76 5.2 USD |
-4.52
|
$0 0 USD | $694 758.64 USD | $4.76 5.2 USD | $5.1 5.57 USD | $0 0 USD | 31.69 | $0.15 0.16 USD | |
| NLS Pharmaceutics NLSPW | $0.04 — |
+51.71
|
$0 — | $85 — | $0.04 — | $0.04 — | $0 — | 0 | $0 — | |
| enVVeno Medical NVNOW | $0.0063 — |
-32.98
|
$0 — | $24.25K — | $0.006 — | $0.01 — | $0 — | 0 | -$1.9 — | |
| Callitas Health MPHMF | $0.0001 — |
+9900
|
$0 — | $19.57K — | $0.0001 — | $0.0001 — | $0 — | 0 | $0 — | |
| Clever Leaves CLVRW | $0.01 — |
0
|
$0 — | $620 — | $0.01 — | $0.01 — | $0 — | 0 | $0 — | |
| Orpea SA OPA0.F | $6.8 7.43 USD |
0
|
$4.45T 4.86T USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.45T 4.86T USD | 0 | $0 0 USD | |
| Eli Lilly and Company LLY.BA | $21,608 25.54 USD |
+1.66
|
$893.84T 1.06T USD | $3.3K 3.9 USD | $21,204.5 25.06 USD | $21,700 25.65 USD | $893.84T 1.06T USD | 0.87 | $24.7K 29.19 USD | |
| Eli Lilly and Company LILY34.SA | $166.4 33.73 USD |
+1.17
|
$4.49T 911.03B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.49T 911.03B USD | 135.28 | $1.23 0.25 USD | |
| Eli Lilly and Company LLY.MX | $16,380 969.9 USD |
-0.06
|
$14.75T 873.3B USD | $13 0.77 USD | $16,380 969.9 USD | $16,380 969.9 USD | $14.75T 873.3B USD | 133.33 | $122.85 7.27 USD | |
| Eli Lilly and Company LLY.SW | $820 932.98 USD |
0
|
$738.33B 840.06B USD | $10 11.38 USD | $805 915.92 USD | $805 915.92 USD | $738.33B 840.06B USD | 135.09 | $6.07 6.91 USD | |
| Eli Lilly and Company LLYC.VI | $845 923.7 USD |
+0.01
|
$760.84B 831.7B USD | $0 0 USD | $845 923.7 USD | $845 923.7 USD | $760.84B 831.7B USD | 133.28 | $6.34 6.93 USD | |
| Eli Lilly and Company LLY.DE | $844.6 923.26 USD |
+0.11
|
$760.48B 831.31B USD | $119 130.08 USD | $843.4 921.95 USD | $844.6 923.26 USD | $760.48B 831.31B USD | 133.42 | $6.33 6.92 USD | |
| Eli Lilly and Company LLY.F | $841.7 920.09 USD |
-0.64
|
$757.87B 828.46B USD | $60 65.59 USD | $841.1 919.44 USD | $841.7 920.09 USD | $757.87B 828.46B USD | 132.55 | $6.35 6.94 USD | |
| Novo Nordisk A/S N1VO34.SA | $99.49 20.16 USD |
-0.49
|
$3.51T 711.72B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.51T 711.72B USD | 6.38 | $15.59 3.16 USD | |
| Novo Nordisk A/S NOVA.F | $133 145.39 USD |
-0.75
|
$596.75B 652.33B USD | $1.04K 1.14K USD | $133 145.39 USD | $133 145.39 USD | $596.75B 652.33B USD | 49.81 | $2.67 2.92 USD | |
| UnitedHealth Group Incorporated UNHH34.SA | $38.32 7.77 USD |
+1.35
|
$2.47T 500.39B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.47T 500.39B USD | 29.93 | $1.28 0.26 USD | |
| UnitedHealth Group Incorporated UNH.MX | $8,782.58 520.04 USD |
0
|
$8.08T 478.63B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08T 478.63B USD | 29.58 | $296.85 17.58 USD | |
| UnitedHealth Group Incorporated UNH.VI | $452.95 495.14 USD |
+0.47
|
$417.94B 456.87B USD | $0 0 USD | $452.95 495.14 USD | $452.95 495.14 USD | $417.94B 456.87B USD | 29.64 | $15.28 16.7 USD | |
| UnitedHealth Group Incorporated UNH.DE | $452.55 494.7 USD |
+0.19
|
$416.79B 455.61B USD | $37 40.45 USD | $452 494.1 USD | $453.15 495.35 USD | $416.79B 455.61B USD | 29.55 | $15.31 16.74 USD | |
| UnitedHealth Group Incorporated UNH.F | $450.8 492.79 USD |
-0.36
|
$414.91B 453.55B USD | $19 20.77 USD | $452.1 494.21 USD | $452.45 494.59 USD | $414.91B 453.55B USD | 29.48 | $15.29 16.71 USD | |
| UnitedHealth Group Incorporated UNH.SN | $487.16 — |
0
|
$448.37B — | $0 — | $0 — | $0 — | $448.37B — | 29.75 | $16.37 — | |
| Johnson & Johnson JNJ.BA | $13,168.5 15.57 USD |
+2.03
|
$350.33T 414.1B USD | $4.79K 5.66 USD | $12,811.5 15.14 USD | $13,187 15.59 USD | $350.33T 414.1B USD | 10.76 | $1.22K 1.45 USD | |
| AstraZeneca PLC AZN.BA | $53,112 62.78 USD |
+1.31
|
$338.33T 399.91B USD | $231 0.27 USD | $52,236.5 61.75 USD | $53,128 62.8 USD | $338.33T 399.91B USD | 1000.79 | $53.07 0.06 USD | |
| Merck & Co., Inc. MRK.BA | $35,444.5 41.9 USD |
+1.4
|
$334.97T 395.95B USD | $379 0.45 USD | $34,838 41.18 USD | $35,692.5 42.19 USD | $334.97T 395.95B USD | 4.33 | $8.18K 9.67 USD | |
| Johnson & Johnson JNJB34.SA | $54.1 10.97 USD |
+1.12
|
$1.95T 395.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.95T 395.85B USD | 22.08 | $2.45 0.5 USD | |
| Johnson & Johnson JNJ.MX | $2,692.4 159.42 USD |
+0.88
|
$6.48T 383.68B USD | $514 30.44 USD | $2,667 157.92 USD | $2,692.4 159.42 USD | $6.48T 383.68B USD | 22.07 | $121.97 7.22 USD | |
| Merck & Co., Inc. MRCK34.SA | $91.08 18.46 USD |
+0.39
|
$1.85T 374.05B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.85T 374.05B USD | 149.31 | $0.61 0.12 USD | |
| Johnson & Johnson JNJ.VI | $137.32 150.11 USD |
+0.09
|
$330.49B 361.27B USD | $0 0 USD | $137.32 150.11 USD | $137.32 150.11 USD | $330.49B 361.27B USD | 21.90 | $6.27 6.85 USD | |
| Merck & Co., Inc. MRK.MX | $2,407.55 142.56 USD |
0
|
$6.1T 361.07B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.1T 361.07B USD | 147.07 | $16.37 0.97 USD | |
| Johnson & Johnson JNJ.DE | $137.22 150 USD |
-0.1
|
$330.24B 361B USD | $45 49.19 USD | $137.22 150 USD | $137.6 150.42 USD | $330.24B 361B USD | 21.81 | $6.29 6.88 USD | |
| Johnson & Johnson JNJ.F | $136.96 149.72 USD |
-0.29
|
$329.62B 360.32B USD | $1.89K 2.06K USD | $136.96 149.72 USD | $136.96 149.72 USD | $329.62B 360.32B USD | 21.77 | $6.29 6.88 USD | |
| Novo Nordisk A/S NVON.MX | $2,600 153.95 USD |
-2.51
|
$6T 355.03B USD | $125 7.4 USD | $2,600 153.95 USD | $2,653.66 157.13 USD | $6T 355.03B USD | 41.87 | $62.09 3.68 USD | |
| Johnson & Johnson JNJ.SN | $145.55 — |
-1.83
|
$350.29B — | $0 — | $0 — | $0 — | $350.29B — | 21.62 | $6.73 — | |
| Merck & Co., Inc. 6MK.DE | $122.8 134.24 USD |
-1.6
|
$311.03B 340B USD | $377 412.11 USD | $122.6 134.02 USD | $123.2 134.67 USD | $311.03B 340B USD | 146.19 | $0.84 0.92 USD | |
| Merck & Co., Inc. MRK.VI | $122.6 134.02 USD |
-1.61
|
$310.52B 339.44B USD | $0 0 USD | $122.6 134.02 USD | $122.6 134.02 USD | $310.52B 339.44B USD | 147.71 | $0.83 0.91 USD | |
| Merck & Co., Inc. 6MK.F | $122.4 133.8 USD |
-1.29
|
$310.02B 338.89B USD | $390 426.32 USD | $122.4 133.8 USD | $122.8 134.24 USD | $310.02B 338.89B USD | 145.71 | $0.84 0.92 USD | |
| AbbVie Inc. ABBV34.SA | $59.16 11.99 USD |
+1.86
|
$1.67T 338.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.67T 338.79B USD | 51.44 | $1.15 0.23 USD | |
| Merck & Co., Inc. MRK.SN | $127.84 — |
0
|
$333.06B — | $0 — | $0 — | $0 — | $333.06B — | 143.64 | $0.89 — | |
| AbbVie Inc. ABBV.MX | $3,150 186.52 USD |
+1.52
|
$5.56T 329.37B USD | $13 0.77 USD | $3,150 186.52 USD | $3,150 186.52 USD | $5.56T 329.37B USD | 51.54 | $61.11 3.62 USD | |
| AbbVie Inc. 4AB.DE | $160.22 175.14 USD |
0
|
$282.93B 309.28B USD | $295 322.47 USD | $159.72 174.6 USD | $160.44 175.38 USD | $282.93B 309.28B USD | 51.02 | $3.14 3.43 USD | |
| AbbVie Inc. ABBV.VI | $160.2 175.12 USD |
+0.06
|
$282.89B 309.24B USD | $0 0 USD | $160.2 175.12 USD | $160.52 175.47 USD | $282.89B 309.24B USD | 51.34 | $3.12 3.41 USD | |
| AbbVie Inc. 4AB.F | $159.02 173.83 USD |
-1.21
|
$280.81B 306.96B USD | $48 52.47 USD | $159.02 173.83 USD | $159.02 173.83 USD | $280.81B 306.96B USD | 50.64 | $3.14 3.43 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC A1ZN34.SA | $73.13 14.82 USD |
+0.84
|
$1.35T 272.87B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.35T 272.87B USD | 19.87 | $3.68 0.75 USD | |
| Novartis AG NVS.BA | $36,026 42.58 USD |
+2.36
|
$230.7T 272.69B USD | $154 0.18 USD | $35,197 41.6 USD | $36,030 42.59 USD | $230.7T 272.69B USD | 4.50 | $8K 9.46 USD | |
| AstraZeneca PLC AZNN.MX | $1,440 85.27 USD |
+1.22
|
$4.48T 265.17B USD | $42 2.49 USD | $1,440 85.27 USD | $1,440 85.27 USD | $4.48T 265.17B USD | 39.21 | $36.72 2.17 USD | |
| AstraZeneca PLC ZEGA.F | $73.5 80.35 USD |
-0.68
|
$228.95B 250.28B USD | $50 54.66 USD | $73.5 80.35 USD | $73.5 80.35 USD | $228.95B 250.28B USD | 38.88 | $1.89 2.07 USD | |
| AstraZeneca PLC ZEG.F | $147.55 161.29 USD |
-1.63
|
$228.74B 250.04B USD | $12 13.12 USD | $147.55 161.29 USD | $147.55 161.29 USD | $228.74B 250.04B USD | 39.03 | $3.78 4.13 USD | |
| AstraZeneca PLC AZNCF | $156.55 — |
0
|
$244.66B — | $139 — | $156.55 — | $156.55 — | $244.66B — | 38.55 | $4.06 — | |
| Roche Holding AG ROGN.MX | $5,345.37 316.51 USD |
0
|
$4.08T 241.87B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.08T 241.87B USD | 18.45 | $289.72 17.15 USD | |
| Novartis AG N1VS34.SA | $59.1 11.98 USD |
+1.34
|
$1.19T 241.64B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.19T 241.64B USD | 2.46 | $23.99 4.86 USD | |
| Thermo Fisher Scientific Inc. TMO.BA | $34,007 40.2 USD |
+2
|
$201.91T 238.67B USD | $14 0.02 USD | $33,573 39.68 USD | $34,007 40.2 USD | $201.91T 238.67B USD | 2.39 | $14.17K 16.75 USD | |
| Thermo Fisher Scientific Inc. TMOS34.SA | $64.23 13.02 USD |
+1.44
|
$1.18T 238.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.18T 238.53B USD | 36.28 | $1.77 0.36 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Novartis AG NVSN.MX | $1,851.08 109.61 USD |
0
|
$3.97T 234.82B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.97T 234.82B USD | 23.20 | $79.78 4.72 USD | |
| Thermo Fisher Scientific Inc. TMO.MX | $10,230 605.74 USD |
+1.32
|
$3.9T 231.22B USD | $130 7.7 USD | $10,170.59 602.22 USD | $10,230 605.74 USD | $3.9T 231.22B USD | 36.23 | $282.35 16.72 USD | |
| Roche Holding AG RHO6.F | $32.2 35.2 USD |
-1.67
|
$206.7B 225.95B USD | $16 17.49 USD | $32.2 35.2 USD | $32.2 35.2 USD | $206.7B 225.95B USD | 17.21 | $1.87 2.04 USD | |
| Novartis AG NOTA.F | $99 108.22 USD |
-1
|
$202.09B 220.91B USD | $80 87.45 USD | $99 108.22 USD | $99 108.22 USD | $202.09B 220.91B USD | 24.08 | $4.11 4.49 USD | |
| Thermo Fisher Scientific Inc. TN8.F | $519.4 567.77 USD |
+0.17
|
$199.3B 217.86B USD | $10 10.93 USD | $518.5 566.79 USD | $518.5 566.79 USD | $199.3B 217.86B USD | 35.64 | $14.57 15.93 USD | |
| Thermo Fisher Scientific Inc. TMOF.VI | $520.3 568.76 USD |
-0.42
|
$198.61B 217.1B USD | $0 0 USD | $520.3 568.76 USD | $520.3 568.76 USD | $198.61B 217.1B USD | 35.80 | $14.53 15.88 USD | |
| Thermo Fisher Scientific Inc. TN8.DE | $518.8 567.12 USD |
-0.67
|
$198.03B 216.48B USD | $20 21.86 USD | $518.8 567.12 USD | $519.5 567.88 USD | $198.03B 216.48B USD | 35.60 | $14.57 15.93 USD | |
| Abbott Laboratories ABT.BA | $35,261 41.68 USD |
+1.65
|
$182.39T 215.6B USD | $171 0.2 USD | $34,356.5 40.61 USD | $35,261 41.68 USD | $182.39T 215.6B USD | 6.04 | $5.84K 6.9 USD | |
| Danaher Corporation DHER34.SA | $51 10.34 USD |
+3.09
|
$1.06T 214.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.06T 214.38B USD | 48.11 | $1.06 0.21 USD | |
| Roche Holding AG RHHBF | $299.3 — |
0
|
$212.19B — | $300 — | $299.3 — | $299.3 — | $212.19B — | 18.69 | $16.01 — | |
| Danaher Corporation DHR.MX | $4,665.95 276.28 USD |
0
|
$3.46T 204.64B USD | $17 1.01 USD | $0 0 USD | $0 0 USD | $3.46T 204.64B USD | 47.16 | $98.92 5.86 USD | |
| Abbott Laboratories ABTT34.SA | $48 9.73 USD |
+0.57
|
$1T 203.09B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1T 203.09B USD | 32.87 | $1.46 0.3 USD | |
| Amgen Inc. AMGN.BA | $14,049 16.61 USD |
+0.39
|
$170.83T 201.92B USD | $493 0.58 USD | $13,820 16.34 USD | $14,049 16.61 USD | $170.83T 201.92B USD | 0.44 | $31.82K 37.62 USD | |
| Abbott Laboratories ABT.MX | $1,908 112.98 USD |
0
|
$3.32T 196.54B USD | $12 0.71 USD | $0 0 USD | $0 0 USD | $3.32T 196.54B USD | 32.78 | $58.19 3.45 USD | |
| Abbott Laboratories ABT.SN | $111.55 — |
-0.77
|
$194.06B — | $0 — | $111.55 — | $111.55 — | $194.06B — | 34.75 | $3.21 — | |
| Danaher Corporation DAP.DE | $238.85 261.1 USD |
+0.08
|
$176.91B 193.39B USD | $101 110.41 USD | $236.95 259.02 USD | $238.85 261.1 USD | $176.91B 193.39B USD | 46.92 | $5.09 5.56 USD | |
| Danaher Corporation DHRC.VI | $238.3 260.49 USD |
0
|
$176.51B 192.94B USD | $0 0 USD | $238.3 260.49 USD | $238.3 260.49 USD | $176.51B 192.94B USD | 46.90 | $5.08 5.55 USD | |
|
لا توجد أسهم مفضَّلة
لا توجد لديك أسهم مفضَّلة حتى الآن؛ لذا يُرجى إضافتها إلى المفضَّلة لرؤيتها هنا |
||||||||||